AzurRx BioPharma

General Information
We are engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Non-systemic biologics are non-absorbable drugs that act locally without reaching the systemic circulation, i.e. the intestinal lumen, skin or mucosa.
Employees: 12
Founded: 2014
Contact Information
Address 760 Parkside Avenue, Downstate Biotechnology Incubator, Suite 217, Brooklyn, NY 11226, US
Phone Number 646-699-7855
Web Address
View Prospectus: AzurRx BioPharma
Financial Information
Market Cap $53.0mil
Revenues $0.0 mil (last 12 months)
Net Income $-6.7 mil (last 12 months)
IPO Profile
Symbol AZRX
Exchange NASDAQ
Shares (millions): 1.0
Price range $5.50 - $5.50
Est. $ Volume $5.3 mil
Manager / Joint Managers WallachBeth Capital/ Network 1 Financial Securities
CO-Managers -
Expected To Trade: 10/11/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change